Possible involvement of enhanced prostaglandin E2 production in the photosensitivity in xeroderma pigmentosum group A model mice

被引:35
作者
Kuwamoto, K
Miyauchi-Hashimoto, H
Tanaka, K
Eguchi, N
Inui, T
Urade, Y
Horio, T
机构
[1] Kansai Med Univ, Dept Dermatol, Moriguchi, Osaka 5708506, Japan
[2] Osaka Univ, Inst Mol & Cellular Biol, Suita, Osaka 565, Japan
[3] Osaka Biosci Inst, Dept Mol Behav Biol, Suita, Osaka 565, Japan
[4] Japan Sci & Technol Corp, CREST, Osaka, Japan
关键词
COX-2; DNA damage; inflammation; immunosuppression;
D O I
10.1046/j.1523-1747.2000.0883x.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Xeroderma pigmentosum group A (XPA) gene-deficient mice cannot repair UV-induced DNA damage and easily develop skin cancers by UV irradiation. Therefore, XPA-deficient mice are a useful model of human XP and represent a promising tool for photobiologic studies of the disorder, Exposure to ultraviolet (UV) B (280-320 nm) radiation greatly enhanced inflammation and immunosuppression in these mice. To investigate the molecular mechanisms of enhanced UV inflammation and immunosuppression, we determined the amount of prostaglandin (PG) E-2, an inflammatory mediator and immunomodulator, and analysed the expression of cyclooxygenase (COX) mRNA in the ear skin of XPA-deficient mice after UV irradiation. In XPA-deficient mice, the amount of PGE(2) significantly increased at 48 and 72 h after UVB irradiation to the level that was 8- and 16-fold higher than those in wild-type mice, respectively. The expression level of COX-2 mRNA increased in a time-dependent manner, although COX-1 mRNA was constantly expressed. Treatment with indomethacin, a potent inhibitor of PG biosynthesis, inhibited UV-induced ear swelling, abrogated local immunosuppression, and decreased the amount of PGE(2) in the ear skin of XPA-deficient mice, These results indicate that the excess DNA photoproducts remaining in XPA-deficient cells after UV radiation may induce COX-2 expression. The induced production of PGE(2) may be involved in the enhanced inflammation and immunosuppression caused by UV radiation in XPA-deficient mice and XP patients.
引用
收藏
页码:241 / 246
页数:6
相关论文
共 37 条
[1]   IDENTIFICATION OF THE MOLECULAR TARGET FOR THE SUPPRESSION OF CONTACT HYPERSENSITIVITY BY ULTRAVIOLET-RADIATION [J].
APPLEGATE, LA ;
LEY, RD ;
ALCALAY, J ;
KRIPKE, ML .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (04) :1117-1131
[2]   TIME COURSE CHANGES IN LEVELS OF ARACHIDONIC-ACID AND PROSTAGLANDINS D2E2F2-ALPHA-IN HUMAN-SKIN FOLLOWING ULTRAVIOLET-B IRRADIATION [J].
BLACK, AK ;
FINCHAM, N ;
GREAVES, MW ;
HENSBY, CN .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 (05) :453-457
[3]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[4]   Prostaglandin E2 primes naive T cells for the production of anti-inflammatory cytokines [J].
Demeure, CE ;
Yang, LP ;
Desjardins, C ;
Raynauld, P ;
Delespesse, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) :3526-3531
[5]   YES, BUT DO THEY STILL GET HEADACHES [J].
DEWITT, D ;
SMITH, WL .
CELL, 1995, 83 (03) :345-348
[6]  
ENK AH, 1992, J IMMUNOL, V149, P92
[7]  
EVENO E, 1995, CANCER RES, V55, P4325
[8]   HIGHER PYRIMIDINE DIMER YIELDS IN SKIN OF NORMAL HUMANS WITH HIGHER UVB SENSITIVITY [J].
FREEMAN, SE ;
GANGE, RW ;
MATZINGER, EA ;
SUTHERLAND, BM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1986, 86 (01) :34-36
[9]   ANALYSIS OF THE MECHANISM OF ULTRAVIOLET-(UV)-B RADIATION-INDUCED PROSTAGLANDIN-E2 SYNTHESIS BY HUMAN EPIDERMOID CARCINOMA-CELLS [J].
GREWE, M ;
TREFZER, U ;
BALLHORN, A ;
GYUFKO, K ;
HENNINGER, H ;
KRUTMANN, J .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 101 (04) :528-531
[10]   INCREASED CONCENTRATIONS OF ARACHIDONIC-ACID, PROSTAGLANDIN-E2, PROSTAGLANDIN-D2 AND PROSTAGLANDIN-6-OXO-F1-ALPHA, AND HISTAMINE IN HUMAN-SKIN FOLLOWING UVA IRRADIATION [J].
HAWK, JLM ;
BLACK, AK ;
JAENICKE, KF ;
BARR, RM ;
SOTER, NA ;
MALLETT, AI ;
GILCHREST, BA ;
HENSBY, CN ;
PARRISH, JA ;
GREAVES, MW .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1983, 80 (06) :496-499